Skip to search formSkip to main contentSkip to account menu

adenocarcinoma of the prostate

Known as: PROSTATE, ADENOCARCINOMA, adenocarcinoma prostatic, Prostate Adenocarcinoma 
An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas… 
National Institutes of Health

Related topics

Related topics

21 relations
BIRC5 geneBIRC5 wt AlleleCARM1 geneCARM1 wt Allele

Broader (2)

Malignant neoplasm of prostateProstate carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate.
PURPOSE A phase I trial was conducted to determine the maximally tolerated dose (MTD) of concurrent weekly docetaxel and three… 
Highly Cited
2003
Highly Cited
2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
Highly Cited
1997
Highly Cited
1997
The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma
Cyclin‐dependent kinases (CDK) and cyclins constitute the subunits of the maturation‐promoting factor that controls the process… 
Highly Cited
1997
Highly Cited
1997
Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.
Highly Cited
1994
Highly Cited
1994
Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma.
Highly Cited
1993
Highly Cited
1993
Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
Highly Cited
1992
Highly Cited
1992
Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.
Prostate-specific antigen (PSA) is the most sensitive marker available for monitoring the progression of prostate cancer and… 
Highly Cited
1988
Highly Cited
1988
Autochthonous prostate adenocarcinomas in Lobund‐Wistar rats: A model system
An experimental model system for autochthonous prostate adenocarcinoma (PA) has been developed in Lobund‐Wistar (L‐W) rats. Large… 
Highly Cited
1983
Highly Cited
1983
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin… 
Highly Cited
1980
Highly Cited
1980
Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)